The Clinical Implications of Tumor Mutational Burden in Osteosarcoma

BACKGROUND: Osteosarcoma (OTS) is aggressive bone malignancy without well-recognized prognosis biomarker. Tumor mutational burden (TMB) has been proved as effective biomarker in predicting clinical outcomes in several cancer types. However, its prognostic value in OTS remains unknown. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Lu, Yang, Yufei, Guo, Wei, Che, Dongxue, Xu, Jie, Sun, Xin, Liu, Kuisheng, Ren, Tingting, Liu, Xingyu, Yang, Yi, Ji, Tao, Tang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059407/
https://www.ncbi.nlm.nih.gov/pubmed/33898301
http://dx.doi.org/10.3389/fonc.2020.595527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059407/
https://www.ncbi.nlm.nih.gov/pubmed/33898301
http://dx.doi.org/10.3389/fonc.2020.595527

Ejemplares similares